Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sony DADC to Enter Into a Manufacturing Agreement with Trinean

Published: Friday, April 04, 2014
Last Updated: Thursday, April 03, 2014
Bookmark and Share
Sony DADC to supply microfluidic disposables for Trinean’s high throughput DropSense96™ spectrometers and its Xpose™ Touch & Go sample QC analyzer.

Trinean has announced that it has entered into a manufacturing and supply agreement with Sony DADC for the production of microfluidic disposables fit for storage and micro-cuvette analysis of droplet-sized biological samples.

Sony DADC BioSciences, the leading OEM supplier of smart polymer-based consumables, is using their ISO 13485 facility in Salzburg, Austria to manufacture to Trinean’s specifications.

“We are very pleased to start working with Sony DADC,” comments Philippe Stas, CEO of Trinean. "The Sony DADC team has an in-depth understanding of microfluidic disposable production and optimization. High optical quality and reproducibility in the production process are crucial for an accurate analysis of DNA, RNA and protein samples”.

Trinean’s spectrophotometers redefine manual UV/VIS bio-sample quantification into a convenient, high speed solution. The DropSense96™ reader is geared to high throughput and integrated sample QC analysis. The Xpose™ ‘Touch & Go’ approach avoids time-consuming sample loading and cleaning steps thereby minimizing the hands-on time on the reader.

Both platforms include proprietary Spectral Content Profiling software for dye-free quantitation of DNA, RNA or protein yields combined with the detection of contaminating levels of residuals for content QC.

“We are delighted to have gained the trust of the Trinean team. Based on our extensive experience in translating polymer science into robust manufacturing processes, we look forward to supplying the microfluidic disposables to Trinean as they grow their global business footprint,” said Dr. Chris Mauracher, Senior Vice President of the BioSciences division of Sony DADC.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sony, M3 and Illumina to Collaborate
Sony and M3 establish a new company with Illumina as a minority investor to launch a "genome information platform" in Japan.
Monday, January 27, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!